Physician Assistant · Lansing, MI
NPI
1114021482
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1140 E Michigan Ave Ste 300
Lansing, MI, 48912
Phone (517) 364-5655
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
614 services
Medicare patients, 2024
319
Average age 74
Drug cost, 2024
$1.1M
3,880 prescriptions
Company payments, 2025
$655
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth M Pelletier was code 99213 (office e&m - established), 273 times for 196 patients. In total Elizabeth M Pelletier billed 614 services in 13 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 273 | 196 | $41.55 | $11K |
| 99214 Office E&M - Established | Facility | 183 | 145 | $61.51 | $11K |
| 99442 Telephone Services | Office | 49 | 43 | $39.97 | $1,959 |
| 99213 Office E&M - Established | Office | 20 | 15 | $43.82 | $876 |
By year: 2022 $26K for 580 services; 2023 $31K for 729 services; 2024 $28K for 614 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth M Pelletier prescribed most often to Medicare patients was Gemtesa (Vibegron), with 713 prescriptions and refills. In total Elizabeth M Pelletier wrote 3,880 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 713 | 1,033 | 169 | $476K |
| Myrbetriq Mirabegron | 575 | 896 | 165 | $387K |
| Estradiol Generic | 502 | 1,478 | 249 | $45K |
| Solifenacin Succinate Generic | 292 | 485 | 86 | $12K |
| Tamsulosin Hcl Generic | 195 | 444 | 71 | $3,947 |
| Mirabegron Er Mirabegron | 165 | 263 | 58 | $82K |
| Cephalexin Generic | 163 | 272 | 103 | $953 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 156 | 226 | 104 | $2,923 |
| Ciprofloxacin Hcl Generic | 115 | 115 | 81 | $371 |
| Trospium Chloride Er Trospium Chloride | 78 | 112 | 24 | $13K |
| Methenamine Hippurate Generic | 77 | 121 | 23 | $6,416 |
| Dutasteride Generic | 74 | 218 | 26 | $4,174 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 62 | 38 | $123 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 51 | 122 | 20 | $1,106 |
| Finasteride Generic | 46 | 121 | 14 | $1,131 |
Brand drugs: - claims; generic drugs: 2,431 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth M Pelletier $655 ($655 in general payments such as food, travel and fees) from 16 companies. The largest payer was Sumitomo Pharma America, Inc. with $215.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 12 | $215 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $62.41 |
| Tolmar, Inc. | 2 | $53.95 |
| Ferring Pharmaceuticals Inc. | 2 | $41.96 |
| Janssen Biotech, Inc. JNJ | 2 | $40.21 |
| Boston Scientific Corporation BSX | 2 | $37.96 |
| Urogen Pharma, Inc. URGN | 1 | $34.23 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25.2 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $24.16 |
| Astellas Pharma US Inc 4503.T | 1 | $21.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.